We've been unfortunately left out of the immunotherapy space. Obviously, we have Sipuleucel-T, but that has a modest benefit. All of the studies that have been done with checkpoint inhibitors ...

There are no data concerning the ability of new therapeutic agents, such as Sipuleucel T or enzalutamide, to cross the BBB.

an α-emitter (radium-223), the bone resorption-targeting drug denosumab and an immunotherapy (sipuleucel-T). This article describes the molecular mechanisms underlying castration resistance ...

“The only therapeutic vaccine that's approved is Provenge (sipuleucel-T) which is a completely different mechanism so we don't know whether this particular oncolytic viral approach will have ...

Immunotherapy in PC is not a new concept. The phase-3 study assessing Sipuleucel-T, demonstrated a 4 months survival benefit to this vaccine. This caused this vaccine to be FDA approved for metastatic ...

Mean fold-change in response at wk 6 over baseline.

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...

T-Mobile is the third-largest wireless carrier in the United States, with its popularity largely down to its network coverage and the wide range of tempting offers available. They span from T ...